UTIRA
Live / Allowed — First extension granted (statement of use) (as of 02 Apr 2026)
What this means for you
Approved and waiting on proof of use. It will register unless the applicant drops it, and its 04 Apr 2025 filing date already counts against anyone who files later.
Record
- Serial number
- 99121663
- Mark type
- Word mark
- Filed
- 04 Apr 2025
- Published for opposition
- 07 Oct 2025
- Attorney of record
- Pamela B. Huff
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical preparations for the treatment of urinary tract infections and related symptoms
Owner
- BIOCOMP PHARMA, INC., San Antonio, TX, US
- BIOCOMP PHARMA, INC., San Antonio, TX, US
Prosecution history
- 03 Apr 2026 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 02 Apr 2026 — SOU EXTENSION 1 GRANTED
- 02 Apr 2026 — SOU EXTENSION 1 FILED
- 02 Apr 2026 — SOU TEAS EXTENSION RECEIVED
- 02 Dec 2025 — NOA E-MAILED - SOU REQUIRED FROM APPLICANT
- 07 Oct 2025 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 07 Oct 2025 — PUBLISHED FOR OPPOSITION
- 01 Oct 2025 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 04 Sept 2025 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 02 Sept 2025 — ASSIGNED TO EXAMINER
- 04 Apr 2025 — APPLICATION FILING RECEIPT MAILED
- 04 Apr 2025 — NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
- 04 Apr 2025 — NEW APPLICATION ENTERED